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ABSTRACT. The purpose of this study was to investigate PAP, peak airway pressure the effects on cerebral hemodynamics of administering EEP, end expiratory pressure modified natural surfactant (Curosurf, 200 mg.kg-') to FiOz, inspired oxygen fraction infants requiring mechanical ventilation for hyaline mem-PVH, periventricular cerebral hemorrhage brane disease. Observations were made using near infrared Paoz, arterial oxygen tension spectroscopy on 20 infants for between 26 and 109 (median Pacoz, arterial carbon dioxide tension 57) min before and 22 to 112 (median 46) min after surfactant instillation. Changes in cerebral oxyhemoglobin concentration and cerebral blood volume (CBV) were monitored continuously; cerebral blood flow, oxygen delivery, and the response of CBV to changes in arterial carbon
There is abundant evidence that surfactant replacement therdioxide tension were measured while the infants were apy improves pulmonary gas exchange and reduces mortality in stable shortly before and after surfactant was given. Cere-infants with hyaline membrane disease (surfactant-deficient resbra1 oxyhemoglobin concentration fell transiently in all piratory distress syndrome) (1) . The effects of this therapy on infants immediately after surfactant by a median of -0. 21 intracerebral complications, such as PVH, that lead to later (range -0.46 to 0.05) m L 100 g-I, but quickly recovered morbidity are less certain. Most randomized trials show no so that the median change during the 10 min after surfac-evidence of a change in the incidence of PVH in infants treated tant was 0.01 (-0.46 to 0.46) mL.lOO g-I. Alterations in with either natural or artificial surfactant (1) . However, in one CBV also occurred ranging from -0.44 to 0.40 (median 0) recent multicenter trial in which an enriched extract of bovine mL. 100 g-I, which represented -12 to 16% of total CBV; lung was used, a substantial increase in the incidence of PVH these changes rapidly resolved. When the infants were was found (2) . Hemorrhages graded as severe occurred in 39% stable before and after surfactant, the values for mean (SD) of treated infants compared with 15% of controls. Concern about cerebral blood flow were 20.5 (7.5) and 23.1 (5.2) mL. 100 the high incidence of PVH in the treated infants prompted the g-' . min-I, respectively (n = 9); for mean cerebral oxygen U.S. Food and Drug Administration to terminate this trial before delivery, values were 2.71 (0.89) and 3.15 (0.73) mL. 100 planned enrollment was completed.
g-' . min-' (n = 9); and for response of CBV to changes in Little information is available about intracerebral consearterial carbon dioxide tension, they were 0.14 (0.09) and quences of surfactant administration that might provoke PVH, 0.11 (0.11) m L 100 g-' . kPa-' (n = 16); these changes although abnormalities of EEG recordings (3) and falls in cerebral were not statistically significant. We conclude that ( I ) arterial blood velocity (4) have been demonstrated coincident surfactant administration caused small, transient pertur-with administration of a natural surfactant derived from porcine bations in cerebral oxyhemoglobin concentration and CBV, lung (Curosurf, Chiesi Farmaceutici, Parma, Italy). The purpose and (2) no important alterations in cerebral blood flow, of this study was to investigate with NIRS the extent of any cerebral oxygen delivery, or response of CBV to changes perturbations in cerebral hemodynamics associated with adminin arterial carbon dioxide tension were detected. (Pediatr istration of surfactant. the-first dose were studied. The infint, nursed supine with the head in the midline, was disconnected from the ventilator circuit and a polythene catheter that passed easily down the endotracheal tube was inserted until the catheter tip rested at the end of the tube. The surfactant was instilled through the catheter as a single bolus over about 2 to 4 s with the head immobile. Mechanical ventilation was immediately restarted using the previous ventilator settings. The aim was to alter FiO, so that the Pao, remained within clinically acceptable limits (8-12 kPa) and to manipulate the peak airway pressure so that the chest movements appeared normal and the Paco, remained at a satisfactory level.
Near infrared spectroscopy. Studies by NIRS were carried out for between 26 and 109 (median 57) min before and 22 to 112 (median 46) min after administration of surfactant. The technique depends on measuring the characteristic absorption, within cerebral tissue, of near infrared light by the chromophores oxyhemoglobin and deoxyhemoglobin (5) . The apparatus used were the NIR 1000 or the NIR 500 (Hamamatsu Photonics KK, Hamamatsu City, Japan), which were commercial prototypes of the machine designed and built at this institution (6).
We have previously described the methods used to measure changes in intracerebral [Hb02] and [Hb] (7), CBV (8) , and its reactivity to alterations in Paco, (CBVR) (9), as well as CBF (10) and COD. Briefly, near infrared light at three (NIR 500) or six (NIR 1000) wavelengths between 779.0 and 907.8 nm was carried to the infant's head through a fiberoptic bundle, the end of which (the optode) was applied to the parietal region. Light emerging from the head was collected from another optode at least 4 cm distant from the first and transmitted to the photomultiplier tube of the spectrometer. The distance between the optodes was measured with mechanical callipers. To prevent interference from background illumination, the infant's head was wrapped in a light-tight bandage.
Changes in intracerebral [HbOz] and [Hb] were calculated from the modified Lambert-Beer law using previously established extinction coefficients (1 1) and assuming an optical path length of 4.39 times the distance between the optodes (12). Measurements were made continuously and averaged into variable time bins for display at the cotside, and the data were recorded on computer disc for later analysis.
Changes in total cerebral hemoglobin concentration ([tHb]) were calculated as the sum of the changes in [HbO,] and [Hb] , and changes in CBV (mL. 100 g-') was calculated from the formula (7):
where k1 is a constant (0.89) reflecting the molecular weight of hemoglobin (64 500), tissue density (1.05) (1 3), and cerebra1:arterial hematocrit ratio (0.69) (14) ; [HI is peripheral arterial Hb concentration.
Absolute values for total CBV ( m L 100 g-I) were obtained after observing the effect of a change of 5-10% in Sao, produced over a period of about 5 min by altering the Fi02. CBV was calculated from the following formula (8):
[HI. ASao,) CBVR (mL. 100 g-' . kPa) was measured after inducing a change in Pac02 of about 1 kPa within or toward the normal range by altering the ventilator rate and observing the effect on CBV (9). CBF (mL. 100 g-I. min-') was estimated using a modification of the Fick principle in which a sudden change in Saoz over 4-6 s induces a change in oxyhemoglobin, which acts as an intravascular and nondiffusible tracer. CBF was calculated from the expression ( 10)
where k2 is a constant reflecting the molecular weight of Hb and tissue density. [Independent studies have shown that this method gave results comparable to those obtained with the i.v. "3Xenon clearance technique in preterm infants (15, 16) .] COD was calculated as the product of arterial oxygen content and CBF.
Statistical analysis. The data were examined to ascertain which samples approximated a normal distribution: if the median and the mean were similar, the SD was calculated; otherwise, the range was determined. Mean CBF, mean COD, and CBVR before and after surfactant were compared using paired t test. The maximum changes in percentage of CBV in infants who subsequently developed PVH were compared with those who did not using the rank sum test, and, using the same test, Fi02 and PAP were compared in infants with and without CBF measurements. Using the SPSS-PC statistical package, changes in [HbOz], CBV, and CBF were analyzed using stepwise multiple linear regression analysis, with the probability of F required for entry into the model set at 0.05. Paco2, Pao2, mean arterial blood pressure, and surfactant administration were analyzed as independent variables, together with a factor to account for variability between individuals. The partitioning of variance was analyzed to determine important correlations. Histograms of studentized residuals were examined, significant outliers were investigated, and relations between variables and residuals were sought to check the applicability of the model.
RESULTS
Ventilator management. Immediately after instillation of surfactant, small increases in both peak airway pressure (PAP) and Fi02 were generally needed to maintain satisfactory chest expansion and Sao2. One-half to 1 min later, it was usually possible to decrease both. One h before surfactant treatment, the median value for PAP was 25 (18-45) cm H20, EEP was 3 (2-5) cm H20, ventilator rate was 30 (20-36) breaths min-I, the inspiration:expiration ratio was 1.0 (1.0-2.0), and FiO2 was 0.72 (0.35-1.00). Individual values for PAP, EEP, and FiO, before and during the 10 min after surfactant are shown in Figure 1 . One h after treatment, the median value for PAP was 24 (18-34) cm H20, EEP was 3 (2-5) cm H20, ventilator rate was 30 (20-50) breaths. min-l, the inspiration:expiration ratio was 1.0 (0.6-1.5), and Fi02 was 0.35 (0.2 1-1.0). Values for Pao2, Paco2, and mean arterial blood pressure before and after treatment are given in Table 1 .
Changes in [HbOz] and CBV during surfactant administration. riods, and Table 1 gives median values for the 5 rnin before and 10 rnin after treatment.
Immediately after disconnection from the ventilator and instillation of surfactant, [Hb02] fell transiently from baseline values (Fig. 2) . The maximum fall in each infant ranged from -0.46 to 0.05 (median -0.21) mL. 100 g-I. This rapidly reversed so that no net change was seen in the group as a whole during the 10 rnin after surfactant (Table 1) . Multiple linear regression analysis showed that surfactant administration had a weak independent relation with [Hb02] but that the largest part of the variation in [Hb02] was explained by a strong positive relation to changes in Pao2 ( p < 0.01). This was not an independent effect of surfactant, because Fi02 was adjusted as part of the administration protocol.
The alteration in CBV immediately after surfactant was inconsistent, ranging from -0.44 to 0.40 (median 0) m L 100 g-I (Fig.  I) . The maximum change observed expressed as a percentage of total CBV ranged from -12 to 16% (median 0%). The changes were transient, and there was no change in the group median (Table I ) although, as with [Hb02], increased variation in CBV after surfactant was observed. Multiple linear regression showed that changes in CBV were not independently related to surfactant administration. Changes in CBV had a strong positive correlation with Paco2 ( p < 0.001) and a slight negative relation to Pao2 ( p < 0.01); no relation to mean arterial blood pressure was found. The maximum percentage change in CBV after surfactant was not significantly different in infants who subsequently developed PVH compared to those who did not, or in infants in whom CBF was measured compared to the remainder.
Values for total CBV before surfactant administration were obtained in 19 infants and ranged from 1.2 to 6.0 (median 3.0) mL. 100 g-I. The median percentage of change in CBV after surfactant is included in Table 1 .
CBF, COD, and CBVR before and after surfactant administration. CBF was measured in nine infants between 6 and 79 (median 23) min before and 1 l and 70 (median 26) min after surfactant. Between one and three (median 2) measurements were made in each infant before and between one and four (3) afterwards. COD was calculated, and individual values for CBF and COD are shown in Figure 3 . Mean values for these variables in each infant are given in Table 2 . No significant effect of surfactant administration could be demonstrated by paired t test.
Multiple linear regression showed a highly significant relation between CBF and Paco2 of 3.4 mL. 100 g-' .min-I. kPa-I ( p < 0.00 1) as illustrated in Figure 4 . No relation was found between CBF and surfactant administration, Pao?, or mean arterial blood pressure. The infants in whom CBF was measured had lower initial median FiOl and PAP compared to the rest of the group (0.50:0.90 and 24:28 cm H20, respectively), but this difference was not statistically significant.
CBVR was tested in 16 infants between 10 and 61 (median 29) min before and between 7 and 80 (median 26) min after surfactant. The median imposed alteration in Paco2 was 0.9 (0.5-1.7) kPa. The individual results are included in Figure 3 and mean values are shown in Table 2 ; no significant change after surfactant administration was found.
Analysis of the distributions of residuals from the various regression models showed that they approximated a gaussian distribution and were unrelated to any variable.
Other results. Cerebral ultrasound scans were normal in 18 of the 20 infants before surfactant; one infant had a germinal layer hemorrhage and another had moderate ventricular dilatation of unknown etiology. In the 7 d after surfactant, three infants developed germinal layer hemorrhages, three developed intraventricular hemorrhages, and three developed hemorrhagic parenchymal infarction. One infant with a large intraventricular hemorrhage later developed periventricular leukomalacia. No relation was found between the variables studied and subsequent hemorrhage. Four infants died, two from the direct effects of their lung disease and two in association with hemorrhagic parenchymal infarction.
DISCUSSION
Numerous investigators have implicated cerebral hemodynamic perturbations in the pathogenesis of PVH, and some evidence suggests that strategies that diminish these perturbations reduce the risk of bleeding (1 7, 18) . It therefore seemed possible that surfactant instillation could under some circumstances induce hemodynamic consequences that might provoke PVH among treated infants, as appears to have been the case in the study of Horbar et al. (2) . Evidence consistent with this hypothesis was obtained by Svenningsen et al. (3) , who gathered EEG data showing periods of electrical silence lasting up to 20 rnin after the administration of surfactant, which they interpreted as evidence of cerebral ischemia (3). The persistent reduction of 36% in middle cerebral artery blood velocity after surfactant administration found by Cowan et al. (4) was also interpreted as resulting from a fall in cerebral blood flow (4) . We have used NIRS to make quantitative observations of cerebral hemodynamic events associated with surfactant instillation.
The indications for giving surfactant in the present study were identical to the criteria defined in a current multicenter randomized trial of surfactant. The infants were all diagnosed as having hyaline membrane disease due to surfactant deficiency, and administration of surfactant usually allowed the expected reduction in Fi02. The severity of lung disease varied among the infants, but overall they appeared representative of infants who currently receive surfactant therapy. Our aim during and after instillation was to minimize alterations to chest movement and blood gases in the belief that this would probably minimize hemodynamic perturbations. We therefore altered ventilation pressures so that chest wall movements appeared satisfactory at the same time as manipulating Fi02 to maintain normal oxygenation.
Our results showed that when surfactant was administered there were immediate small fluctuations in [Hb02] and CBV (Fig. 3) . A rapid but short-lived decline in [HbOz] took place, which was related to the fall in Pao2 caused by disconnection from the ventilator.
[Hb02] recovered on reconnection and there was no persisting decline in cerebral oxygenation. The acute alterations in CBV that were observed in all infants after surfactant were closely related to changes in Pao2 and Pace,. Transient alterations of -12 to 16% of CBV were observed, probably related to changes in venous blood volume. However, changes, of this order have been observed during endotracheal suction (19) , and the falls in CBV were considerably smaller than the persistent falls that follow the administration of indomethacin to preterm infants for treatment of patent ductus arteriosus (20) . The median of the maximum change in CBV was 0%.
Comparison of values for CBF, COD, and CBVR made shortly time (minutes) Fig. 3 . Values for COD (n = 9), CBF (n = 9), and CBVR (n = 16) before and after surfactant administration. Surfactant was administered at 0 min. 
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before and after surfactant when the infants were in a stable condition showed no significant changes (Table 1) . Values for CBF and COD were comparable to those previously obtained by NIRS and other techniques (20, 21) . Because no effect of giving surfactant on these variables could be detected, these results do not suggest that this treatment causes persistent cerebral ischemia, although they do not exclude transient effects. The numbers of infants in this study limited its ability to detect small changes; however, the observation of a strong relation between CBF and Pacoz (Fig. 4) shows that no effect greater than the effect of alterations in Paco, would have been missed. Because of this relation, CBF and COD are likely to have increased slightly rather than fallen during and after treatment due to the small associated rise in Paco2 (Table 1) .
Values for CBVR all fell within the 95% confidence limits for previously studied infants with normal brains (9) . It has been suggested that a component of Curosurf might have an effect on the microvascular control of blood flow because flushing of the skin has been observed after treatment (4). We saw no such effect, and our finding that CBVR and the response of CBF to changes in Pacon (22) both appeared normal demonstrated that this aspect of microvascular control remained unimpaired. In addition, we found no relation between CBV or CBF and mean arterial blood pressure, which implies that cerebral perfusion remained independent of alterations in mean arterial blood pressure.
The present investigation was not designed to test the relation between cerebral hemodynamics and subsequent PVH. Nevertheless, perturbations associated with surfactant administration were no greater in the infants who developed PVH than in those who did not.
The results of this study of the effects of treatment with surfactant on cerebral oxygenation and hemodynamics do not provide evidence of persistent changes in CBV, CBF, COD, or CBVR. The transient changes that were observed in CBV were relatively small and seem unlikely to be an independent factor provoking hemorrhage, although we cannot rule out the possibility. The incidence of PVH in the studies of Horbar et al. (2) therefore remains unexplained. It is possible that the details of the protocol for giving surfactant are important. For example, in our study we set out to minimize the effects of surfactant administration on chest movement, whereas the protocol of Horbar et al. (2) stated that immediately after the instillation of surfactant the Fi02 could be altered but not the airway pressure. Temporary obstruction of the airways might have caused an acute episode of impaired gas exchange. Alternatively, if the lung rapidly became more compliant as a result of treatment, it is possible that the intrathoracic circulation became obstructed, creating a situation analogous to the development of tension pneumothorax, which can be an important antecedent of PVH (23) . Although these are many ways in which the cerebral circulation might be affected by the administration of surfactant, our results show that the procedure need not cause persistent major perturbations.
